110 related articles for article (PubMed ID: 16874014)
41. Phase I study of paclitaxel with oral etoposide in advanced solid tumors.
Perez EA; Coe T; Turrell C; Lau D; Campbell D; Gandara D
Cancer J Sci Am; 1996; 2(5):286-90. PubMed ID: 9166546
[TBL] [Abstract][Full Text] [Related]
42. Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.
Thiery-Vuillemin A; Dobi E; Nguyen T; Royer B; Montange D; Maurina T; Kalbacher E; Bazan F; Villanueva C; Demarchi M; Chaigneau L; Ivanaj A; Pivot X
Anticancer Drugs; 2010 Nov; 21(10):958-62. PubMed ID: 20856105
[TBL] [Abstract][Full Text] [Related]
43. Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol.
Casanova M; Ferrari A; Bisogno G; Merks JH; De Salvo GL; Meazza C; Tettoni K; Provenzi M; Mazzarino I; Carli M
Cancer; 2004 Oct; 101(7):1664-71. PubMed ID: 15378498
[TBL] [Abstract][Full Text] [Related]
44. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP
J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757
[TBL] [Abstract][Full Text] [Related]
45. A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group.
Cairo MS; Krailo MD; Weinthal JA; Secola R; Bergeron S; van de Ven C; Blazar BR; Garrison L; Reaman GH
Cancer; 1998 Oct; 83(7):1449-60. PubMed ID: 9762948
[TBL] [Abstract][Full Text] [Related]
46. Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors.
Peyrl A; Chocholous M; Kieran MW; Azizi AA; Prucker C; Czech T; Dieckmann K; Schmook MT; Haberler C; Leiss U; Slavc I
Pediatr Blood Cancer; 2012 Sep; 59(3):511-7. PubMed ID: 22147459
[TBL] [Abstract][Full Text] [Related]
47. Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck.
Wirth LJ; Haddad RI; Lindeman NI; Zhao X; Lee JC; Joshi VA; Norris CM; Posner MR
J Clin Oncol; 2005 Oct; 23(28):6976-81. PubMed ID: 16172459
[TBL] [Abstract][Full Text] [Related]
48. A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
Ozkaynak MF; Sahdev I; Gross TG; Levine JE; Cheerva AC; Richards MK; Rozans MK; Shaw PJ; Kadota RP
J Pediatr Hematol Oncol; 2008 Mar; 30(3):204-9. PubMed ID: 18376282
[TBL] [Abstract][Full Text] [Related]
49. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
50. Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil.
Loss JF; Santos PP; Leone LD; Brunetto AL
Pediatr Blood Cancer; 2004 Feb; 42(2):139-44. PubMed ID: 14752877
[TBL] [Abstract][Full Text] [Related]
51. Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib.
Johnson K; Notrica DM; Carpentieri D; Jaroszewski D; Henry MM
J Pediatr Hematol Oncol; 2013 Jul; 35(5):414-6. PubMed ID: 23669730
[TBL] [Abstract][Full Text] [Related]
52. Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours.
Ali AM; El-Sayed MI
Curr Oncol; 2016 Jun; 23(3):e253-9. PubMed ID: 27330362
[TBL] [Abstract][Full Text] [Related]
53. Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study.
McCarville MB; Coleman JL; Guo J; Li Y; Li X; Honnoll PJ; Davidoff AM; Navid F
AJR Am J Roentgenol; 2016 May; 206(5):933-9. PubMed ID: 26999488
[TBL] [Abstract][Full Text] [Related]
54. SFCE METRO-01 four-drug metronomic regimen phase II trial for pediatric extracranial tumor.
Heng-Maillard MA; Verschuur A; Aschero A; Dabadie A; Jouve E; Chastagner P; Leblond P; Aerts I; De Luca B; André N
Pediatr Blood Cancer; 2019 Jul; 66(7):e27693. PubMed ID: 30920117
[TBL] [Abstract][Full Text] [Related]
55. Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-center Study.
Sakurai Y; Iwasaki F; Hirose A; Matsumoto N; Miyagawa N; Keino D; Yokosuka T; Hamanoue S; Yanagimachi M; Shiomi M; Goto S; Tanaka M; Tanaka Y; Nozawa K; Goto H
J Pediatr Hematol Oncol; 2024 Jul; 46(5):233-240. PubMed ID: 38691057
[TBL] [Abstract][Full Text] [Related]
56. Role of metronomic therapy for advanced oral cancers and predictors of response: Multi-institutional feasibility study.
Sultania M; Imaduddin M; S V Deo S; Kar M; K Muduly D; Kumar S; Sharma A; Mishra A; K D Majumdar S; K Adhya A; K Parida D
Head Neck; 2022 Jan; 44(1):104-112. PubMed ID: 34708450
[TBL] [Abstract][Full Text] [Related]
57. Retrospective National "Real Life" Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol.
Winnicki C; Leblond P; Bourdeaut F; Pagnier A; Paluenzela G; Chastagner P; Duhil-De Benaze G; Min V; Sudour-Bonnange H; Piette C; Entz-Werle N; Chabaud S; André N
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835950
[TBL] [Abstract][Full Text] [Related]
58. Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors.
Selt F; Deiß A; Korshunov A; Capper D; Witt H; van Tilburg CM; Jones DT; Witt R; Sahm F; Reuss D; Kölsche C; Ecker J; Oehme I; Hielscher T; von Deimling A; Kulozik AE; Pfister SM; Witt O; Milde T
Brain Pathol; 2016 Jul; 26(4):506-16. PubMed ID: 26445087
[TBL] [Abstract][Full Text] [Related]
59. Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature.
Carcamo B; Francia G
J Clin Med; 2022 May; 11(10):. PubMed ID: 35628975
[TBL] [Abstract][Full Text] [Related]
60. Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach.
Slavc I; Mayr L; Stepien N; Gojo J; Aliotti Lippolis M; Azizi AA; Chocholous M; Baumgartner A; Hedrich CS; Holm S; Sehested A; Leblond P; Dieckmann K; Haberler C; Czech T; Kool M; Peyrl A
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
